0 Σχόλια
0 Μοιράστηκε
249 Views
0 Προεπισκόπηση
Προωθημένο
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Alzheimer’s Disease Market: Early Diagnostic Biomarkers, Disease-Modifying Therapeutic Pipeline, and Cognitive Health Management Strategies"Comprehensive Outlook on Executive Summary Alzheimer’s Disease Market Size and Share Data Bridge Market Research analyzes that the Alzheimer’s disease market which was USD 5.10 billion in 2022, is likely to reach USD 9.73 billion by 2030, and is expected to undergo a CAGR of 8.40% during the forecast period. The Alzheimer’s Disease report includes a range of...0 Σχόλια 0 Μοιράστηκε 681 Views 0 Προεπισκόπηση
-
Alzheimer’s Therapeutics Market Poised for Strong Expansion Amid Rising Disease PrevalencePolaris Market Research has introduced a new market research report entitled Alzheimer’s Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Manufactured Combination); By Distribution Channel; By Region; Segment Forecast, 2022 - 2030, which acts as a reliable resource for analyzing historic and...0 Σχόλια 0 Μοιράστηκε 527 Views 0 Προεπισκόπηση
-
Blood-based Biomarker for Alzheimer’s Disease Market Growth Outlook, Opportunities and Forecast 2035The global blood-based biomarker for Alzheimer’s disease market is emerging as a transformative segment within the broader neurodiagnostics and precision medicine landscape. Alzheimer’s disease, a progressive neurodegenerative disorder, continues to impose a significant clinical, social, and economic burden worldwide. Traditional diagnostic approaches relying on cerebrospinal fluid...0 Σχόλια 0 Μοιράστηκε 361 Views 0 Προεπισκόπηση
-
Global Alzheimer’s Disease Diagnostic Market Expands Rapidly with Advances in Early Detection TechnologiesGlobal Alzheimer’s Disease Diagnostic Market Expands Rapidly with Advances in Early Detection Technologies The global Alzheimer’s disease diagnostic market is witnessing substantial growth, driven by the rising prevalence of neurodegenerative disorders, increasing awareness regarding early diagnosis, and rapid advancements in diagnostic technologies. As healthcare...0 Σχόλια 0 Μοιράστηκε 49 Views 0 Προεπισκόπηση
-
Global Alzheimer’s Drugs Market Size, Share, and Industry Outlook by 2031The Alzheimer's drugs market has emerged as a crucial segment within the global pharmaceutical and neurological therapeutics sector. Alzheimer's disease is a progressive neurodegenerative condition that gradually affects memory, cognitive abilities, and behavior. With the global population aging at a steady pace, the number of individuals diagnosed with Alzheimer's disease is increasing...0 Σχόλια 0 Μοιράστηκε 261 Views 0 Προεπισκόπηση
-
CNS Biomarkers Market to Reach USD 11.34 Billion by 2033, Growing at 8.66% CAGRThe global central nervous system biomarkers market size was valued at USD 5.37 billion in 2024 and is projected to grow USD 5.84 billion in 2025 to USD 11.34 billion by 2033, growing at a CAGR of 8.66% during the forecast period (2025-2033). According to Straits Research, this report provides a clear understanding of the Central Nervous System Biomarkers Market Growth by...0 Σχόλια 0 Μοιράστηκε 585 Views 0 Προεπισκόπηση
Προωθημένο
Προωθημένο
English
Arabic
French
Spanish
Portuguese
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)